Pharmacy financial figures: gross profit, gross margin, NOI and EBITDA

Understand the numbers behind your pharmacy sale, with a reconciled example from revenue and gross margin to sustainable earnings.

Educational owner resource. Read the cited sources and obtain advice for your circumstances.

Which pharmacy financial numbers matter in a sale?

Revenue describes the size of a pharmacy. Gross profit shows what remains after the cost of the goods sold. Operating earnings show what remains after running the store. Buyers need all three, together with the evidence explaining how they connect. A large prescription business can still have weak transferable earnings if occupancy, staffing or service costs absorb its contribution.

Use consistent periods and definitions before comparing stores. Separate dispensary, front shop and clinical-service activity in your supporting schedules, then reconcile the total to the accountant’s statements. This is an owner preparation framework, rather than a claim about typical Canadian pharmacy margins.

Gross profit versus gross margin

Gross profit = revenue minus cost of goods sold. Gross margin = gross profit divided by revenue, multiplied by 100. The first is a dollar amount; the second is a percentage. Your accountant should confirm where purchasing adjustments, supplier rebates, inventory movements and direct service costs belong. Consistency matters when comparing periods. Business Development Bank of Canada

Purely illustrative example: $4,000,000 of annual revenue less $3,000,000 of cost of goods sold leaves $1,000,000 gross profit and a 25% gross margin. These are invented teaching figures, not pharmacy benchmarks or transaction comparables. A margin change is a question to investigate: did the product mix, reimbursement, purchasing, returns or accounting treatment change?

Operating income and NOI: agree the definition

Operating income commonly reflects profit after operating expenses and depreciation/amortization, before interest and income tax. “Net operating income” or NOI is sometimes used differently in management reports, lending discussions and real estate. Never assume a pharmacy’s NOI equals EBITDA. State exactly which expenses the reported figure includes and provide a bridge. Business Development Bank of Canada

In the same fictional store, $680,000 of cash operating expenses reduces $1,000,000 gross profit to $320,000 before depreciation and amortization. After $40,000 of depreciation and amortization, operating income is $280,000. If a report calls that figure NOI, its definition must say so. A separate property NOI must not be mixed with the pharmacy’s trading earnings.

EBITDA, normalized EBITDA and the owner’s actual cash

EBITDA means earnings before interest, income taxes, depreciation and amortization. In our simplified example, $50,000 interest and $60,000 income tax reduce $280,000 operating income to $170,000 net income. Adding back those three deductions—$50,000, $60,000 and $40,000—reconciles to $320,000 EBITDA. Business Development Bank of Canada

Normalization then tests sustainable successor earnings. Suppose there is a supported $20,000 non-recurring expense and a missing $30,000 annual replacement-staffing cost. Normalized EBITDA becomes $310,000. Maintain the invoices, payroll assumptions and explanation behind each adjustment; avoid counting the same cost twice.

EBITDA is not cash available to distribute. Loan principal repayments, income tax, equipment replacement and additional working capital can use cash. A buyer’s financing structure also affects its cash outcome. Keep store profitability, owner compensation and personal after-tax sale proceeds in separate schedules.

How these figures factor into pharmacy valuation

A buyer can use gross-margin trends to investigate earnings quality, then assess whether normalized operating earnings are repeatable after the handover. Margin alone does not determine a sale price. Staffing coverage, lease terms, concentration, compliance and transaction structure affect the assessment.

Prepare three years of statements, current monthly results, an inventory reconciliation, payroll by role and a documented EBITDA bridge. Explain unusual changes before a buyer finds them. Smith & Bederman Advisory Group can help owners organize the sale discussion; the accountant should confirm the accounting treatment and a qualified valuation professional can address formal valuation needs.

A useful question for your next review

Ask: “Can another owner reproduce these earnings while paying the people and costs needed to run this pharmacy?” If the answer needs assumptions, write them down. Use the Resource Centre’s EBITDA add-back tool to organize the bridge, then discuss the underlying records in a confidential consultation.

Continue reading

EBITDA add-backs: what to support, what to challenge and what to subtract

What is your pharmacy worth? Start with earnings, then define the price

Pharmacy sale inventory and working capital: understand the price adjustments

Sources and context

Gross margin
General definitions of gross profit and gross margin; no pharmacy-specific margin benchmark.

Income statement
General financial-statement framework. Pharmacy account classifications must be reconciled with the accountant.

EBITDA
General EBITDA definitions; not a valuation or free-cash-flow forecast for a particular pharmacy.

Browse all articles and exit guides →

Plan your next conversation

Smith & Bederman Advisory Group supports independent Canadian pharmacy owners with sales, acquisitions, valuation and succession planning.

Explore valuation and EBITDA tools · Check exit readiness · Book a confidential consultation

Calculator access, full buyer profiles and downloads are available through the Resource Centre’s access form.